(210) | Number of the EPO application | 16703620 |
(220) | Filing date of the EPO application | 2016.01.05 |
(80) | EPO patent specification publication (B) | EPB nr. 33/2019, 2019.08.14 |
(110) | EPO patent number | 3242887 |
(11) | Number of the document | MD 3242887 T2 |
(21) | Number of the application | e 2017 0269 |
(71) | Name(s) of applicant(s), code of the country | ELI LILLY AND COMPANY, US; |
(72) | Name(s) of inventor(s), code of the country | ALSINA-FERNANDEZ Jorge, US; BOKVIST Bengt Krister, US; COSKUN Tamer, US; CUMMINS Robert Chadwick, US; |
(73) | Name(s) of owner(s), code of the country | ELI LILLY AND COMPANY, US; |
(54) | Title of the invention | GIP and GLP-1 co-agonist compounds |
(13) | Kind-of-document code | T2 |
(51) | International Patent Classification | C07K 14/575 (2006.01.01); C07K 14/605 (2006.01.01); A61K 38/26 (2006.01.01) |
(19) | Country | US |
(41) | Date of publication of the application | 2018.02.28 |
(49) | Date of publication of the translation of the validated European patent specification | 2019.11.30 |
(30) | Priority | 201562101488 P, 2015.01.09, US |
(74) | Patent attorney | (Procedură) PARASCA Dumitru, str. Eminescu nr. 40, ap. 13, c/p 28, MD-2012, Chişinău, Republica Moldova |
(86) | International application | PCT/US2016/012124, 2016.01.05 |
(87) | International publication | WO 2016/111971, 2016.07.14 |